Results 241 to 250 of about 1,122,864 (370)

Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV

, 2023
Rongrong Liu, Yunhua Lv, Wenjie Sun, Min Li, Ningning Ge, Cheng Zhu, Yaxin Ding, Ziyu Liu, Ruixue Ma, Yuxiao Huang, Shiyuan Hou, Qikang Ying, Tianle Gu, Fang Wang, Lingling Nie, Youchun Wang, Weijin Huang, Jiayi Shu, Xingan Wu   +18 more
openalex   +1 more source

The TamA protein as a subunit vaccine improves immune protection against highly virulent <i>Klebsiella pneumoniae</i> infection in mice. [PDF]

Curr Res Microb Sci
Liu L, Zhang S, Wu F, Zhao L, Zhao H, Li D, Yang F, Liu L.   +7 more
europepmc   +1 more source

Optimized ACE2‐Fc fusion proteins with picomolar neutralization activity against highly evolved SARS‐CoV‐2 variants

Protein Science, Volume 35, Issue 2, February 2026.
Abstract The rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has compromised the efficacy of many authorized monoclonal antibody products. This highlights the need for alternative strategies, especially for vulnerable populations such as immunocompromised individuals.
Ferran Abancó, Ferran Tarrés‐Freixas, Rosalba Lepore, Elisa Molina‐Molina, Eloi Franco, Rytis Boreika, Edwards Pradenas, Dàlia Raïch‐Regué, Itziar Erkizia, Bonaventura Clotet, Alfonso Valencia, Júlia Vergara‐Alert, Joaquim Segalés, Jorge Carrillo, Nuria Izquierdo‐Useros, Julià Blanco, Benjamin Trinité   +16 more
wiley   +1 more source

A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

, 2018
Serge van de Witte, Jos Nauta, Emanuele Montomoli, Jos Weckx   +3 more
openalex   +1 more source

Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT G protein‐coupled receptors (GPCRs) are integral to numerous biological processes and are associated with various diseases across all therapeutic areas. Consequently, GPCRs present substantial potential for antibody‐based therapies. This review offers an overview of the therapeutic GPCR‐antibody target landscape and examines the diversity ...
Catherine J. Hutchings, Serbülent Ünsal, Mathieu Rappas, Matthew Barnes, Maria Waldhoer, Ben Holland, Martin Culka   +6 more
wiley   +1 more source

Effectively Evaluating a Novel Consensus Subunit Vaccine Candidate to Prevent the H9N2 Avian Influenza Virus [PDF]

Qi Wu, Weihua Wang, Xuehua Zhang, Ding Li, Mei Mei   +4 more
openalex   +1 more source

A Novel Chimeric Fiber-C4/D11 Subunit Vaccine Induces Cross-Neutralizing Antibodies and Provides Better Protection Against Fowl Adenovirus (FAdV) Type 4 and Type 11 Than the Fiber-D11/C4 Subunit Vaccine. [PDF]

Vet Sci
Wang X, Zhao K, Lei B, Jiang W, Qiao Y, Yuan W.   +5 more
europepmc   +1 more source

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model‐Based Meta‐Analysis

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 2, February 2026.
ABSTRACT The objectives of this study were to quantify the relationship between vaccine‐induced immunogenicity responses and the protection against respiratory syncytial virus (RSV) infection‐related clinical outcomes, and to evaluate immunogenicity as a surrogate marker for vaccine efficacy (VE) to accelerate RSV vaccine development.
Yushi Kashihara, Li Qin, Shinji Shimizu, Paul Matthias Diderichsen, Masakatsu Kotsuma, Kazutaka Yoshihara   +5 more
wiley   +1 more source

Development of a subunit vaccine against infectious bursal disease virus

, 1999
Wing-shing Yeung
openalex   +1 more source

Decadal advances and future prospects in subunit vaccine development against <i>Streptococcus suis</i> infection. [PDF]

Front Immunol
Fang L, Ning J.
europepmc   +1 more source